Tata Elxsi Q2 FY27 Earnings Call: Margin Expands 70 Bps Despite Wage Hikes, Four Multi-Year Deal Wins Announced (TATAELXSI)

Broad-Based Growth Quarter with Margin Expansion Despite Wage Hikes

• Revenue of Rs.1,055.7 crore — up 2.3% QoQ in constant currency in Q2 FY 2026-2027, with growth reported across all verticals; management described the quarter as satisfying.
• EBITDA of Rs.231.4 crore — up 7.1% QoQ and 19.7% YoY, with margin at 21.9% (+70 bps QoQ), achieved despite the annual wage revision.
• Vertical growth (CC QoQ) — Transportation +2%, Media & Communication +3.4%, Healthcare & Life Sciences +3.5% in Q2 FY 2026-2027.
• Regional mix — US and India strong; Europe soft, driven by automotive weakness.
• H1 FY 2026-2027 growth of ~15% YoY — yet management reiterated its policy of not providing annual guidance for FY 2026-2027.

New Multi-Year Wins, But Ramp-Ups Take Time

• Four key Q2 FY 2026-2027 wins — multi-year cloud telematics deal from a leading automotive OEM; GenAI virtual assistant engagement with a global tech leader; partnership with Sarla Aviation for eVTOL (Shunya); home dialysis systems engagement with a global renal care leader.
• Automotive exceeded expectations — driven by deal wins in US and India offsetting European weakness; Media & Communication and Healthcare met expectations, with healthcare having bottomed out in Q1 FY 2026-2027.
• Large automotive deal not yet fully ramped — management guided that deal ramp-ups typically take 2-3 quarters to reach full scale.
• A&D deals need 2-3 quarters to ramp — through FY 2027-2028; Nitin Pai noted these innovation/product engineering deals carry reasonably flat margins from the start, unlike typical IT consolidation deals.
• Revenue leakage improved vs FY 2025-2026 — Nitin Pai attributed this to a protected base from large multi-year deals and reduced weight of supplier-side automotive revenues, the primary leakage source over the prior 5-6 quarters.
• 'Others' segment (Smart Manufacturing, BPS) grew ~60-70% YoY in FY26-27 — trending to ~75%, but remains only ~2% of revenue, confirming early-stage experimentation.

Europe Still Cautious; Group Relationships a Support

• European demand in Q2 FY 2026-2027 similar to Q1 FY 2026-2027 — no ramp downs but slow ramp ups and some project runoffs; management remains cautious on Europe.
• European OEM decision-making delays persist — large deals stuck in "wait and watch" mode for Q3/Q4 FY 2026-2027; Europe flattish in transportation.
• Proposed limits on Chinese vehicle imports into Europe — management does not expect them to meaningfully change European OEM spending trajectory in the near term, citing systemic issues like cost base and electrification as the primary challenges.
• JLR's business challenges (layoffs) acknowledged — CEO Manoj Raghavan said management is closely monitoring across H2 FY26-27, while confirming Tata Elxsi remains involved in most new JLR car programs.
• Strong engagement with Tata Motors — on electrification, design, and connected car programs, with new vehicle launches creating ongoing R&D opportunities; management noted a significant portion of Automotive growth in FY26-27 is coming from outside group customers (US, India, Asia) and does not disclose group-customer revenue contribution.
• Automotive revenue split not disclosed — recent growth driven by US and India, with Europe's relative share decreasing QoQ, though it remains a significant region.

AI Budget Pressure Continues, But With Growing ROI Pragmatism

• Enterprise AI budgets continue to impact discretionary ER&D budgets — the trend noted in Q1 FY 2026-2027 continued in Q2 FY 2026-2027, though enterprises are showing greater pragmatism and a focus on ROI from AI spends.
• AI-first offerings positioned as an H2 growth lever — management is focused on sustaining H2 FY 2026-2027 growth via AI-first offerings and operational excellence.
• On-site to offshore split at ~25-75 — in Q2 FY 2026-2027, considered industry-leading; management noted margins are driven by project value and customer stickiness, not solely contract type.
• GCC demand for R&D talent remains high — CEO Manoj Raghavan flagged the need for active retention; variable performance-linked pay is already in place for middle to senior management.

Margin Bridge: Currency, Leverage and Pyramid Correction

• Q2 margin bridge quantified by CFO Nitin Rana — 60-70 bps from cross-currency benefits and 10-20 bps from operational leverage and one-off reversals, together sufficient to offset wage hikes.
• Utilization at 78% in Q2 FY 2026-2027 — vs a historical peak of 81-82% pre-COVID, indicating headroom; junior hiring is being calibrated.
• FY 2026-2027 salary hikes complete — allowing operational leverage to play out through the rest of the year.
• Pyramid correction planned over H2 FY 2026-2027 — to fix a senior-heavy mix built over the last 4-6 quarters, leveraging a trained junior bench.
• Gradual EBITDA margin improvement guided over the next 2-3 quarters — towards end of FY 2026-2027, via operational leverage, utilization and pyramid correction; no specific margin target was provided.
• H1 FY 2026-2027 margins were impacted by one-time costs (Q1) and employee salary adjustments (Q2).

H2 Better Than H1, With Europe the Key Watch Item

• H2 FY 2026-2027 expected better than H1 FY 2026-2027 on a YoY basis — per CFO Nitin Rana, driven by signed deals in Media & Communication and Healthcare.
• Q3 FY 2026-2027 growth trajectory guided to continue — though management flagged Q3 is typically a short quarter with possible furloughs.
• Sustaining Q3/Q4 FY 2026-2027 momentum requires both ramp-ups and new wins — as project-based business naturally experiences ramp-downs.
• Margin improvement in H2 FY 2026-2027 is gradual and calibrated — measured against the H2 FY26 base.
• European automotive softness flagged as a continued risk — even as management expects H2 improvement across most verticals.
• HLS diversification progressing — management acknowledged past client concentration risk but cited customer and geography diversification (e.g., Bayer in Germany, Terumo in Japan) over the past ~5-6 quarters up to Q2 FY 2026-2027.